Puma Biotechnology Q4 2021 Earnings Preview

• Puma Biotechnology (NASDAQ:PBYI) is scheduled to announce Q4 earnings results on Thursday, March 3rd, after market close.
• The consensus EPS Estimate is $0.01 (+107.1% Y/Y) and the consensus Revenue Estimate is $47.17M (-10.3% Y/Y).
• Over the last 2 years, PBYI has beaten EPS estimates 63% of the time and has beaten revenue estimates 63% of the time.